# Vascular Neurology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Liliʻuokalani (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET024-SYN
- Date: 2026-03-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Henrik Abernethy-Sato, MD
- Calendar frame: modern shifted

- Requested by: Kealani Morrison-Takeda, MD

## Reason for consultation

About 20 minutes of right hand weakness and word-finding difficulty yesterday afternoon in a 78-year-old woman, fully resolved, ABCD2 score 5. Same-day emergency evaluation today; please see her at the rapid-access stroke clinic tomorrow morning to confirm the diagnosis, find the cause and set her secondary prevention plan. **S**

## History

Liliʻuokalani, a 78-year-old Native Hawaiian composer, is seen at the request of Dr. Morrison-Takeda the morning after her emergency evaluation, with two members of her ʻohana whom she asked to come. Two days ago, while playing the piano, she had about 20 minutes of weakness and clumsiness of the right hand and difficulty finding words, which recovered completely. She has had no recurrence, palpitations, headache or bleeding since aspirin and clopidogrel were loaded about 18 hours after onset. She asked for a plain explanation and wants to make her own decisions, with her ʻohana informed. **S**

## Examination

| System | Finding |
|---|---|
| General | Alert and composed; blood pressure 148/86, pulse 70 and regular |
| Neurological | NIH Stroke Scale 0; fluent speech with normal naming and repetition; no drift; normal grip and rapid finger movements of both hands; normal gait |
| Neck | No carotid bruit |

BP 148/86 mmHg; pulse 70 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 58 kg; BMI 22.7 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Morrison-Takeda's note and ECG (sinus rhythm). Emergency department: non-contrast CT with no hemorrhage; CT angiography with no large-vessel occlusion or intracranial stenosis and a calcified plaque at the origin of the left internal carotid artery narrowing it by less than 50%; bedside swallow screen passed; hemoglobin 12.8 g/dL, platelets 232, creatinine 0.82 mg/dL, glucose 98 mg/dL, INR 1.0, hemoglobin A1c 5.5%, LDL 132 mg/dL. This morning: MRI with diffusion showing an 8 mm acute infarct in the cortex of the left precentral gyrus and mild small-vessel white matter changes; transthoracic echocardiogram with an ejection fraction of 60%, a mildly enlarged left atrium (37 mL/m2) and no thrombus. MoCA 26. NIH Stroke Scale: 0; LVEF by echocardiogram: 60%; Left atrial volume index: 37 mL/m² (high); MoCA: 26; PHQ-2: 1. All results are synthetic.

## Assessment

1. **Minor ischemic stroke, left precentral cortex** (I63.412). By the tissue-based definition this was a minor ischemic stroke, not a transient ischemic attack: the symptoms resolved, but the MRI shows an infarct in the hand area of the left motor cortex. A single small cortical infarct is embolic in pattern. The likeliest sources are the heart, particularly atrial fibrillation, given her age and a mildly enlarged left atrium, and less likely the left carotid plaque, which narrows the artery by less than 50%. Until a source is found, this is an embolic stroke of undetermined source. **S**
2. **Antiplatelet therapy** (I63.412). Yes. For a minor noncardioembolic stroke or high-risk TIA, aspirin with clopidogrel started within 24 hours and given for 21 days lowers early recurrence (CHANCE, POINT); hers was started at about 18 hours. Bleeding risk rises if it is continued longer, so after 21 days she should take a single antiplatelet, clopidogrel, unless atrial fibrillation is found. **S**
3. **Rhythm monitoring and atrial fibrillation** (I63.412). An embolic-appearing stroke at 78 warrants at least 30 days of ambulatory monitoring; a 30-day patch was applied today. If atrial fibrillation is found, stop the antiplatelet and start a direct oral anticoagulant: apixaban 5 mg twice daily, since she meets only one dose-reduction criterion (weight 60 kg or less). With a small infarct and no hemorrhage, anticoagulation can begin as soon as atrial fibrillation is confirmed. **S**
4. **Carotid plaque**. Less than 50% narrowing does not warrant endarterectomy or stenting; treatment is a statin, blood pressure control and her antithrombotic. No follow-up carotid imaging is needed unless new symptoms arise. **S**
5. **Targets and screening** (I10). Blood pressure below 130/80 mmHg, with treatment started a few days after the stroke; an ARB or thiazide is suitable, at a low starting dose for her size. LDL below 70 mg/dL with atorvastatin 40 mg, adding ezetimibe if needed. She passed the swallow screen; MoCA 26 is normal and should be repeated within the first year; PHQ-9 at the first follow-up; falls assessment before anticoagulation and at each visit; a sleep apnea screen. **S**

## Recommendations

1. Aspirin 81 mg and clopidogrel 75 mg daily to complete 21 days, then clopidogrel 75 mg alone.
2. 30-day ambulatory rhythm monitoring (applied today).
3. If atrial fibrillation is found: stop clopidogrel and start apixaban 5 mg twice daily, with a blood count and kidney function first.
4. Atorvastatin 40 mg daily; lipid panel in four to twelve weeks; LDL goal below 70 mg/dL.
5. Home blood pressure readings; if the average stays 130/80 mmHg or higher after the first week, start losartan 25 mg daily with potassium and creatinine in two weeks; target below 130/80.
6. No carotid procedure and no routine follow-up carotid imaging.
7. MoCA again within the first year; PHQ-9 and a sleep apnea screen at the three-month review; falls assessment at each visit.
8. BE FAST and 911 for any new symptom, even if it passes.
9. Her Native Hawaiian healing practices can continue alongside this plan; any bodywork such as lomilomi should use gentle pressure once she takes an anticoagulant.

## Strengths and supports

- Strengths, supports and purpose: her music, her faith, her ʻohana, her work for the welfare of Hawaiian children, and a steadfast, composed manner **S**

## Communication

Discussed with Dr. Morrison-Takeda, who saw her the same day. The MRI and the plan were explained plainly to Liliʻuokalani and to the members of her ʻohana she invited; she asked questions and agreed to the monitor, the antiplatelets and the statin. **S**

## Follow-up

Dr. Morrison-Takeda continues her care, with the monitor result at about five weeks. Video review with vascular neurology at three months, or sooner with any new symptom. **S**

## Guideline basis

- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association (2021), American Heart Association and American Stroke Association (Stroke 2021;52(7):e364-e467)
- Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association (2021), American Heart Association and American Stroke Association (Stroke 2021;52(9):e558-e571)
- Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) (2018), New England Journal of Medicine 2018;379(3):215-225
- Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) (2013), New England Journal of Medicine 2013;369(1):11-19
- 2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke (2024), American College of Cardiology (J Am Coll Cardiol 2025;85(6):657-681)
- 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (2023), American College of Cardiology, American Heart Association, American College of Chest Physicians and Heart Rhythm Society (Circulation 2024;149(1):e1-e156)
- CMID: Clinical Monitoring Intelligence Database, stroke and transient ischemic attack, atrial fibrillation and hypertension monographs (2026), Aether Forge
